MOA-728

Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain

Study Evaluating MOA-728 Administered in Healthy Men

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone

Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain

Dose Ranging Study in Healthy Methadone Maintenance Subjects

Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

Study Evaluating the Safety and Tolerability of a New Intravenous Formulation of MOA-728 in Healthy Subjects

Bioequivalence Study in Healthy Volunteers

Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects

Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects

A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair